-
1
-
-
0342906187
-
Heterogeneity of multiple sclerosis lesions: Implications for the pathogenesis of demyelination
-
Lucchinetti C, Bruck W, Parisi J, Scheithauer B, Rodriguez M, Lassmann H. Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination. Ann Neurol 2000 47: 707 17.
-
(2000)
Ann Neurol
, vol.47
, pp. 707-17
-
-
Lucchinetti, C.1
Bruck, W.2
Parisi, J.3
Scheithauer, B.4
Rodriguez, M.5
Lassmann, H.6
-
2
-
-
0042591142
-
Chemokines and matrix metalloproteinase-9 in leukocyte recruitment to the central nervous system
-
Sellebjerg F, Sorensen TL. Chemokines and matrix metalloproteinase-9 in leukocyte recruitment to the central nervous system. Brain Res Bull 2003 61: 347 55.
-
(2003)
Brain Res Bull
, vol.61
, pp. 347-55
-
-
Sellebjerg, F.1
Sorensen, T.L.2
-
3
-
-
0033536062
-
CCR5(+) and CXCR3(+) T cells are increased in multiple sclerosis and their ligands MIP-1alpha and IP-10 are expressed in demyelinating brain lesions
-
Balashov KE, Rottman JB, Weiner HL, Hancock WW. CCR5(+) and CXCR3(+) T cells are increased in multiple sclerosis and their ligands MIP-1alpha and IP-10 are expressed in demyelinating brain lesions. Proc Natl Acad Sci U S A 1999 96: 6873 8.
-
(1999)
Proc Natl Acad Sci U S a
, vol.96
, pp. 6873-8
-
-
Balashov, K.E.1
Rottman, J.B.2
Weiner, H.L.3
Hancock, W.W.4
-
4
-
-
0034256028
-
Expression of the beta-chemokine receptors CCR2, CCR3 and CCR5 in multiple sclerosis central nervous system tissue
-
Simpson J, Rezaie P, Newcombe J, Cuzner ML, Male D, Woodroofe MN. Expression of the beta-chemokine receptors CCR2, CCR3 and CCR5 in multiple sclerosis central nervous system tissue. J Neuroimmunol 2000 108: 192 200.
-
(2000)
J Neuroimmunol
, vol.108
, pp. 192-200
-
-
Simpson, J.1
Rezaie, P.2
Newcombe, J.3
Cuzner, M.L.4
Male, D.5
Woodroofe, M.N.6
-
5
-
-
0033559346
-
Expression of specific chemokines and chemokine receptors in the central nervous system of multiple sclerosis patients
-
Sorensen TL, Tani M, Jensen J et al. Expression of specific chemokines and chemokine receptors in the central nervous system of multiple sclerosis patients. J Clin Invest 1999 103: 807 15.
-
(1999)
J Clin Invest
, vol.103
, pp. 807-15
-
-
Sorensen, T.L.1
Tani, M.2
Jensen, J.3
-
6
-
-
0035157253
-
CCR1+/CCR5+ mononuclear phagocytes accumulate in the central nervous system of patients with multiple sclerosis
-
Trebst C, Sorensen TL, Kivisakk P et al. CCR1+/CCR5+ mononuclear phagocytes accumulate in the central nervous system of patients with multiple sclerosis. Am J Pathol 2001 159: 1701 10.
-
(2001)
Am J Pathol
, vol.159
, pp. 1701-10
-
-
Trebst, C.1
Sorensen, T.L.2
Kivisakk, P.3
-
7
-
-
18544404188
-
Distinct chemokine receptor and cytokine expression profile in secondary progressive MS
-
Sorensen TL, Sellebjerg F. Distinct chemokine receptor and cytokine expression profile in secondary progressive MS. Neurology 2001 57: 1371 6.
-
(2001)
Neurology
, vol.57
, pp. 1371-6
-
-
Sorensen, T.L.1
Sellebjerg, F.2
-
8
-
-
0036784205
-
Expression of chemokine receptors in the different clinical forms of multiple sclerosis
-
Martinez-Caceres EM, Espejo C, Brieva L et al. Expression of chemokine receptors in the different clinical forms of multiple sclerosis. Mult Scler 2002 8: 390 5.
-
(2002)
Mult Scler
, vol.8
, pp. 390-5
-
-
Martinez-Caceres, E.M.1
Espejo, C.2
Brieva, L.3
-
9
-
-
0033622321
-
CCR5 delta32, matrix metalloproteinase-9 and disease activity in multiple sclerosis
-
Sellebjerg F, Madsen HO, Jensen CV, Jensen J, Garred P. CCR5 delta32, matrix metalloproteinase-9 and disease activity in multiple sclerosis. J Neuroimmunol 2000 102: 98 106.
-
(2000)
J Neuroimmunol
, vol.102
, pp. 98-106
-
-
Sellebjerg, F.1
Madsen, H.O.2
Jensen, C.V.3
Jensen, J.4
Garred, P.5
-
10
-
-
0031783562
-
Chemokine receptors and their crucial role in human immunodeficiency virus infection: Major breakthroughs in HIV research
-
Kristiansen TB, Knudsen TB, Eugen-Olsen J. Chemokine receptors and their crucial role in human immunodeficiency virus infection: major breakthroughs in HIV research. Scand J Immunol 1998 48: 339 46.
-
(1998)
Scand J Immunol
, vol.48
, pp. 339-46
-
-
Kristiansen, T.B.1
Knudsen, T.B.2
Eugen-Olsen, J.3
-
11
-
-
0038796251
-
A mutated CCR5 gene may have favorable prognostic implications in MS
-
Kantor R, Bakhanashvili M, Achiron A. A mutated CCR5 gene may have favorable prognostic implications in MS. Neurology 2003 61: 238 40.
-
(2003)
Neurology
, vol.61
, pp. 238-40
-
-
Kantor, R.1
Bakhanashvili, M.2
Achiron, A.3
-
12
-
-
0035996209
-
Disease severity in Danish multiple sclerosis patients evaluated by MRI and three genetic markers (HLA-DRB1*1501, CCR5 deletion mutation, apolipoprotein E)
-
Schreiber K, Oturai AB, Ryder LP et al. Disease severity in Danish multiple sclerosis patients evaluated by MRI and three genetic markers (HLA-DRB1*1501, CCR5 deletion mutation, apolipoprotein E). Mult Scler 2002 8: 295 8.
-
(2002)
Mult Scler
, vol.8
, pp. 295-8
-
-
Schreiber, K.1
Oturai, A.B.2
Ryder, L.P.3
-
13
-
-
0034070679
-
CC-chemokine receptor 5 polymorphism and age of onset in familial multiple sclerosis. Multiple Sclerosis Genetics Group
-
Barcellos LF, Schito AM, Rimmler JB et al. CC-chemokine receptor 5 polymorphism and age of onset in familial multiple sclerosis. Multiple Sclerosis Genetics Group. Immunogenetics 2000 51: 281 8.
-
(2000)
Immunogenetics
, vol.51
, pp. 281-8
-
-
Barcellos, L.F.1
Schito, A.M.2
Rimmler, J.B.3
-
14
-
-
0031444113
-
The CCR5 deletion mutation fails to protect against multiple sclerosis
-
Bennetts BH, Teutsch SM, Buhler MM, Heard RN, Stewart GJ. The CCR5 deletion mutation fails to protect against multiple sclerosis. Hum Immunol 1997 58: 52 9.
-
(1997)
Hum Immunol
, vol.58
, pp. 52-9
-
-
Bennetts, B.H.1
Teutsch, S.M.2
Buhler, M.M.3
Heard, R.N.4
Stewart, G.J.5
-
15
-
-
0037180415
-
The chemokine receptor CCR5 deletion mutation is associated with MS in HLA-DR4-positive Russians
-
Favorova OO, Andreewski TV, Boiko AN et al. The chemokine receptor CCR5 deletion mutation is associated with MS in HLA-DR4-positive Russians. Neurology 2002 59: 1652 5.
-
(2002)
Neurology
, vol.59
, pp. 1652-5
-
-
Favorova, O.O.1
Andreewski, T.V.2
Boiko, A.N.3
-
16
-
-
2642570186
-
Association of CCR5 delta32 deletion with early death in multiple sclerosis
-
Gade-Andavolu R, Comings DE, MacMurray J et al. Association of CCR5 delta32 deletion with early death in multiple sclerosis. Genet Med 2004 6: 126 31.
-
(2004)
Genet Med
, vol.6
, pp. 126-31
-
-
Gade-Andavolu, R.1
Comings, D.E.2
MacMurray, J.3
-
17
-
-
2342469322
-
Increase in CCR5 Delta32/Delta32 genotype in multiple sclerosis
-
Pulkkinen K, Luomala M, Kuusisto H et al. Increase in CCR5 Delta32/Delta32 genotype in multiple sclerosis. Acta Neurol Scand 2004 109: 342 7.
-
(2004)
Acta Neurol Scand
, vol.109
, pp. 342-7
-
-
Pulkkinen, K.1
Luomala, M.2
Kuusisto, H.3
-
18
-
-
3042741204
-
Influence of CCR5 delta32 polymorphism on multiple sclerosis susceptibility and disease course
-
Silversides JA, Heggarty SV, McDonnell GV, Hawkins SA, Graham CA. Influence of CCR5 delta32 polymorphism on multiple sclerosis susceptibility and disease course. Mult Scler 2004 10: 149 52.
-
(2004)
Mult Scler
, vol.10
, pp. 149-52
-
-
Silversides, J.A.1
Heggarty, S.V.2
McDonnell, G.V.3
Hawkins, S.A.4
Graham, C.A.5
-
19
-
-
0032511573
-
CCR5 promoter polymorphism and HIV-1 disease progression. Multicenter AIDS Cohort Study (MACS)
-
McDermott DH, Zimmerman PA, Guignard F, Kleeberger CA, Leitman SF, Murphy PM. CCR5 promoter polymorphism and HIV-1 disease progression. Multicenter AIDS Cohort Study (MACS). Lancet 1998 352: 866 70.
-
(1998)
Lancet
, vol.352
, pp. 866-70
-
-
McDermott, D.H.1
Zimmerman, P.A.2
Guignard, F.3
Kleeberger, C.A.4
Leitman, S.F.5
Murphy, P.M.6
-
20
-
-
0035212393
-
Regulation of chemokine receptor CCR5 and production of RANTES and MIP-1alpha by interferon-beta
-
Zang YC, Halder JB, Samanta AK, Hong J, Rivera VM, Zhang JZ. Regulation of chemokine receptor CCR5 and production of RANTES and MIP-1alpha by interferon-beta. J Neuroimmunol 2001 112: 174 80.
-
(2001)
J Neuroimmunol
, vol.112
, pp. 174-80
-
-
Zang, Y.C.1
Halder, J.B.2
Samanta, A.K.3
Hong, J.4
Rivera, V.M.5
Zhang, J.Z.6
-
21
-
-
18844482559
-
Interferon-beta 1a does not reduce expression of CCR5 and CXCR3 on circulating T cells
-
Kivisakk P, Cotleur AC, Lee JC, Rudick RA, Ransohoff RM. Interferon-beta 1a does not reduce expression of CCR5 and CXCR3 on circulating T cells. J Neuroimmunol 2003 141: 150 4.
-
(2003)
J Neuroimmunol
, vol.141
, pp. 150-4
-
-
Kivisakk, P.1
Cotleur, A.C.2
Lee, J.C.3
Rudick, R.A.4
Ransohoff, R.M.5
-
22
-
-
4444251943
-
Selective suppression of chemokine receptor CXCR3 expression by interferon-beta1a in multiple sclerosis
-
Sorensen TL, Sellebjerg F. Selective suppression of chemokine receptor CXCR3 expression by interferon-beta1a in multiple sclerosis. Mult Scler 2002 8: 104 7.
-
(2002)
Mult Scler
, vol.8
, pp. 104-7
-
-
Sorensen, T.L.1
Sellebjerg, F.2
-
23
-
-
0038546727
-
Microarray analysis identifies interferon beta-regulated genes in multiple sclerosis
-
Koike F, Satoh J, Miyake S et al. Microarray analysis identifies interferon beta-regulated genes in multiple sclerosis. J Neuroimmunol 2003 139: 109 18.
-
(2003)
J Neuroimmunol
, vol.139
, pp. 109-18
-
-
Koike, F.1
Satoh, J.2
Miyake, S.3
-
24
-
-
0034855936
-
Complex immunomodulatory effects of interferon-beta in multiple sclerosis include the upregulation of T helper 1-associated marker genes
-
Wandinger KP, Sturzebecher CS, Bielekova B et al. Complex immunomodulatory effects of interferon-beta in multiple sclerosis include the upregulation of T helper 1-associated marker genes. Ann Neurol 2001 50: 349 57.
-
(2001)
Ann Neurol
, vol.50
, pp. 349-57
-
-
Wandinger, K.P.1
Sturzebecher, C.S.2
Bielekova, B.3
-
25
-
-
33745868391
-
Dynamic T-lymphocyte chemokine receptor expression induced by interferon-beta therapy in multiple sclerosis
-
Krakauer M, Sorensen PS, Khademi M, Olsson T, Sellebjerg F. Dynamic T-lymphocyte chemokine receptor expression induced by interferon-beta therapy in multiple sclerosis. Scand J Immunol 2006 64: 155 63.
-
(2006)
Scand J Immunol
, vol.64
, pp. 155-63
-
-
Krakauer, M.1
Sorensen, P.S.2
Khademi, M.3
Olsson, T.4
Sellebjerg, F.5
-
26
-
-
3142661927
-
Differential roles for CCR5 expression on donor T cells during graft-versus-host disease based on pretransplant conditioning
-
Wysocki CA, Burkett SB, Panoskaltsis-Mortari A et al. Differential roles for CCR5 expression on donor T cells during graft-versus-host disease based on pretransplant conditioning. J Immunol 2004 173: 845 54.
-
(2004)
J Immunol
, vol.173
, pp. 845-54
-
-
Wysocki, C.A.1
Burkett, S.B.2
Panoskaltsis-Mortari, A.3
-
27
-
-
2342486058
-
Chemokine inhibition-why, when, where, which and how?
-
Johnson Z, Power CA, Weiss C et al. Chemokine inhibition-why, when, where, which and how? Biochem Soc Trans 2004 32 (Pt 2 366 77.
-
(2004)
Biochem Soc Trans
, vol.32
, Issue.2
, pp. 366-77
-
-
Johnson, Z.1
Power, C.A.2
Weiss, C.3
-
28
-
-
0021035886
-
Rating neurologic impairment in multiple sclerosis: An Expanded Disability Status Scale (EDSS)
-
Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an Expanded Disability Status Scale (EDSS). Neurology 1983 33: 1444 52.
-
(1983)
Neurology
, vol.33
, pp. 1444-52
-
-
Kurtzke, J.F.1
-
29
-
-
0034955141
-
Recommended diagnostic criteria for multiple sclerosis: Guidelines from the International Panel on the diagnosis of multiple sclerosis
-
McDonald WI, Compston A, Edan G et al. Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol 2001 50: 121 7.
-
(2001)
Ann Neurol
, vol.50
, pp. 121-7
-
-
McDonald, W.I.1
Compston, A.2
Edan, G.3
-
30
-
-
0035371942
-
A new multiplex PCR strategy for the simultaneous determination of four genetic polymorphisms affecting HIV-1 disease progression
-
Kristiansen TB, Knudsen TB, Ohlendorff S, Eugen-Olsen J. A new multiplex PCR strategy for the simultaneous determination of four genetic polymorphisms affecting HIV-1 disease progression. J Immunol Methods 2001 252: 147 51.
-
(2001)
J Immunol Methods
, vol.252
, pp. 147-51
-
-
Kristiansen, T.B.1
Knudsen, T.B.2
Ohlendorff, S.3
Eugen-Olsen, J.4
-
31
-
-
0035198252
-
B cells and professional APCs recruit regulatory T cells via CCL4
-
Bystry RS, Aluvihare V, Welch KA, Kallikourdis M, Betz AG. B cells and professional APCs recruit regulatory T cells via CCL4. Nat Immunol 2001 2: 1126 32.
-
(2001)
Nat Immunol
, vol.2
, pp. 1126-32
-
-
Bystry, R.S.1
Aluvihare, V.2
Welch, K.A.3
Kallikourdis, M.4
Betz, A.G.5
|